Gilead drug acquired in $5B buyout fails key blood cancer trial
Roche, Alnylam ink potential $2.8B RNAi partnership for hypertension
Pfizer, Gilead, GSK to capture growing infectious disease market as JNJ pulls back
Bavarian Nordic cans respiratory vaccine
*please scroll down for all the latest news*
